In immunocompromised mice, CRAMP (homologue of human cathelicidin) knockout resulted in increased susceptibility to dermal and respiratory infections (Nizet et al., 2001; Kovach et al., 2012). The gene discussed is CAMP; the disease is respiratory tract infectious disorder.